According to Yagi et al. [70], glucagon may promote colon cancer cell growth by regulating the 5′ adenosine monophosphate-activated protein kinase (AMPK) and mitogen-activated protein kinase (MAPK) pathways. Here, WNK2 is linked to colonic neoplasm.